Immunity to murine chlamydial genital infection

Infection and Immunity

Volumn 70, Issue 6, 2002, Pages 2741-2751

  Morrison, Richard P ^a   Caldwell, Harlan D ^a  

^a MONTANA STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; GENITAL TRACT INFECTION; HISTOPATHOLOGY; IMMUNITY; INFECTION PREVENTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY; VACCINATION;

ANIMALS; BACTERIAL VACCINES; CHLAMYDIA INFECTIONS; CHLAMYDIA TRACHOMATIS; DISEASE MODELS, ANIMAL; FEMALE UROGENITAL DISEASES; HUMANS; IMMUNITY, ACTIVE; MALE UROGENITAL DISEASES; MICE;

EID: 0036263421     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.6.2741-2751.2002     Document Type: Short Survey

References (126)

1. Amino acid requirements of strains of Chlamydia trachomatis and C. psittaci growing in McCoy cells: Relationship with clinical syndrome and host origin
2. Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma
3. Mapping antigenic domains expressed by Chlamydia trachomatis major outer membrane protein genes
4. A new animal model for the study of Chlamydia trachomatis genital infections: Infection of mice with the agent of mouse pneumonitis
5. + T lymphocyte-mediated lysis of Chlamydia-infected L cells using an endogenous antigen pathway
6. Morphologic and antigenic characterization of interferon-gamma mediated persistent Chlamydia trachomatis infection in vitro
7. Persistent chlamydiae: From cell culture to a paradigm for chlamydial pathogenesis
8. Chlamydia trachomatis cytotoxicity associated with complete and partial cytotoxin genes
9. Current methods of laboratory diagnosis of Chlamydia trachomatis infections
10. Cellular responses to interferon-γ
11. Human immunity to chlamydiae
12. Systemic Chlamydia trachomatis infection in mice: A comparison of lymphogranuloma venereum and trachoma biovars
13. The potential for vaccine development against chlamydial infection and disease
14. Induction of tryptophan catabolism is the mechanism for gamma-interferon-mediated inhibition of intracellular Chlamydia psittaci replication in T24 cells
15. Local Th1-like responses are induced by intravaginal infection of mice with the mouse pneumonitis biovar of Chlamydia trachomatis
16. Antigenic analysis of the major outer membrane protein of Chlamydia spp.
17. Use of a live chlamydial vaccine to prevent ovine enzootic abortion
18. Protective efficacy of major outer membrane protein-specific immunoglobulin A (IgA) and IgG monoclonal antibodies in a murine model of Chlamydia trachomatis genital tract infection
19. Dissemination of Chlamydia trachomatis chronic genital tract infection in gamma interferon gene knockout mice
20. Mouse strain-dependent variation in the course and outcome of chlamydial genital tract infection is associated with differences in host response
21. Does inhibition of tumor necrosis factor alpha affect chlamydial genital tract infection in mice and guinea pigs?
22. Early local cytokine profiles in strains of mice with different outcomes from chlamydial genital tract infection
23. Intravaginal inoculation of mice with the Chlamydia trachomatis mouse pneumonitis biovar results in infertility
24. A new computer model for estimating the impact of vaccination protocols and its application to the study of Chlamydia trachomatis genital infections
25. Priming with Chlamydia trachomatis major outer membrane protein (MOMP) DNA followed by MOMP ISCOM boosting enhances protection and is associated with increased immunoglobulin A and Th1 cellular immune responses
26. Emended description of the order Chlamydiales, proposal of Parachlamydiaceae fam. nov. and Simkaniaceae fam. nov., each containing one monotypic genus, revised taxonomy of the family Chlamydiaceae, including a new genus and five new species, and standards for the identification of organisms
27. + T cells recognize an inclusion membrane-associated protein from the vacuolar pathogen Chlamydia trachomatis
28. Background and current knowledge of Chlamydia pneumoniae and atherosclerosis
29. Cell biology
30. Inhibition of TRIC agents by virus-induced interferon
31. Developmental biology
32. Chlamydia trachomatis major outer membrane protein epitopes expressed as fusions with LamB in an attenuated aroA strain of Salmonella typhimurium; their application as potential immunogens
33. The intracellular adhesion molecule type-1 is required for rapid activation of T helper type 1 lymphocytes that control early acute phase of genital chlamydial infection in mice
34. Immune control of chlamydial growth in the human epithelial cell line RT4 involves multiple mechanisms that induce nitric oxide induction, tryptophan catabolism and iron deprivation
35. + T cells in antichlamydial immunity defined by Chlamydia-specific T-lymphocyte clones
36. Induction of protective immunity against Chlamydia trachomatis genital infection by a vaccine based on major outer membrane protein-lipophilic immune response-stimulating complexes
37. Chlamydial infection in inducible nitric oxide synthase knockout mice
38. Inflammation and clearance of Chlamydia trachomatis in enteric and nonenteric mucosae
39. Resolution of murine chlamydial genital infection by the adoptive transfer of a biovar-specific, Th1 lymphocyte clone
40. Integrin-mediated epithelial-T cell interaction enhances nitric oxide production and increased intracellular inhibition of Chlamydia
41. Role of gamma interferon in controlling murine chlamydial genital tract infection
42. Immunological memory in B-cell-deficient mice conveys long-lasting protection against genital tract infection with Chlamydia trachomatis by rapid recruitment of T cells
43. Genital tract infection with Chlamydia trachomatis fails to induce protective immunity in gamma interferon receptor-deficient mice despite a strong local immunoglobulin A response
44. B-cell-deficient mice develop complete immune protection against genital tract infection with Chlamydia trachomatis
45. Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo
46. Accumulation of chlamydial lipopolysaccharide antigen in the plasma membranes of infected cells
47. Effect of interferon and interferon inducers on infections with a nonviral intracellular microorganism, Chlamydia trachomatis
48. Identification of homing receptors that mediate the recruitment of CD4 T cells to the genital tract following intravaginal infection with Chlamydia trachomatis
49. + CTLs specific for the major outer membrane protein of Chlamydia trachomatis in human genital tract infections
50. + CTLs with HLA class I tetramers
51. Risk factors for Chlamydia trachomatis pelvic inflammatory disease among sex workers in Nairobi
52. Gamma interferon production by cytotoxic T lymphocytes is required for resolution of Chlamydia trachomatis infection
53. Role of L3T4-bearing T-cell populations in experimental murine chlamydial salpingitis
54. A critical role for B cells in the development of memory CD4 cells
55. Plaque formation by and plaque cloning of Chlamydia trachomatis biovar trachoma
56. Chlamydial metabolism as inferred from the complete genome sequence
57. The mucosal immune system: From fundamental concepts to vaccine development
58. Fc receptor regulation of protective immunity against Chlamydia trachomatis
59. Differential sensitivities of Chlamydia trachomatis strains to inhibitory effects of gamma interferon
60. Gene knockout mice establish a primary protective role for major histocompatibility complex class II-restricted responses in Chlamydia trachomatis genital tract infection
61. In situ analysis of the evolution of the primary immune response in murine Chlamydia trachomatis genital tract infection
62. + T cells
63. + T cells
64. Characterization of neutrophils and T lymphocytes associated with the murine vaginal epithelium
65. Behavioral and serological human immunodeficiency virus risk factors among female commercial sex workers in Cambodia
66. Vaccination of mice with DNA plasmids coding for the Chlamydia trachomatis major outer membrane protein elicits an immune response but fails to protect against a genital challenge
67. Role of Nramp-deletion in Chlamydia infection in mice
68. Immunization with the Chlamydia trachomatis mouse pneumonitis major outer membrane protein can elicit a protective immune response against a genital challenge
69. Monoclonal immunoglobulin A antibody to the major outer membrane protein of the Chlamydia trachomatis mouse pneumonitis biovar protects mice against a chlamydial genital challenge
70. Immunization with an acellular vaccine consisting of the outer membrane complex of Chlamydia trachomatis induces protection against a genital challenge
71. In vitro neutralization of Chlamydia trachomatis with monoclonal antibody to an epitope on the major outer membrane protein
72. Immunity to Chlamydia trachomatis is mediated by T helper 1 cells through IFN-γ-dependent and -independent pathways
73. Neither interleukin-6 nor inducible nitric oxide synthase is required for clearance of Chlamydia trachomatis from the murine genital tract epithelium
74. Clearance of Chlamydia trachomatis from the murine genital mucosa does not require perforin-mediated cytolysis or Fas-mediated apoptosis
75. Distinct homing pathways direct T lymphocytes to the genital and intestinal mucosae in Chlamydia-infected mice
76. Differential sensitivity of distinct Chlamydia trachomatis isolates to IFN-γ-mediated inhibition
77. Functional and structural mapping of Chlamydia trachomatis species-specific major outer membrane protein epitopes by use of neutralizing monoclonal antibodies
78. Effect of immunoglobulin G isotype on the infectivity of Chlamydia trachomatis in a mouse model of intravaginal infection
79. Inducible nitric oxide synthase does not affect resolution of murine chlamydial genital tract infections or eradication of chlamydiae in primary murine cell culture
80. Resolution of chlamydial genital infection with antigen-specific T-lymphocyte lines
81. Resolution of chlamydial genital infection in B-cell-deficient mice and immunity to reinfection
82. Models of immunity
83. Effect of gamma interferon on resolution of murine chlamydial genital infection
84. Chronic chlamydial genital infection in congenitally athymic nude mice
85. Cytotoxic-T-lymphocyte-mediated cytolysis of L cells persistently infected with Chlamydia spp.
86. Genome sequences of Chlamydia trachomatis MoPn and Chlamydia pneumoniae AR39
87. Localization of chlamydial group antigen in McCoy cell monolayers infected with Chlamydia trachomatis or Chlamydia psittaci
88. Vaccination with temperature-sensitive mutant of Chlamydia psittaci against enzootic abortion of ewes
89. Effect of interferon on the growth of Chlamydia trachomatis in mouse fibroblasts (L cells)
90. Infection and disease epidemiology
91. Murine cytotoxic T lymphocytes induced following Chlamydia trachomatis intraperitoneal or genital tract infection respond to cells infected with multiple serovars
92. Protective cytotoxic T-lymphocytes are induced during murine infection with Chlamydia trachomatis
93. Genomic autobiographies of chlamydiae
94. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis
95. Sequence analysis of the major outer membrane protein gene from Chlamydia trachomatis serovar L2
96. Examination of chlamydial glycolipid with monoclonal antibodies: Cellular distribution and epitope binding
97. + T cells play a significant role in adoptive immunity to Chlamydia trachomatis infection of the mouse genital tract
98. Chlamydia trachomatis genital tract infection of antibody-deficient gene knockout mice
99. Vaccination against chlamydial genital tract infection after immunization with dendritic cells pulsed ex vivo with nonviable Chlamydiae
100. Subclinical chlamydial infection of the female mouse genital tract generates a potent protective immune response: Implications for the development of live attenuated chlamydial vaccine strains
101. Protective efficacy of a parenterally administered MOMP-derived synthetic oligopeptide vaccine in a murine model of Chlamydia trachomatis genital tract infection: Serum neutralizing IgG antibodies do not protect against chlamydial genital tract infection
102. Chlamydia trachomatis-host cell interactions: Role of the chlamydial major outer membrane protein as an adhesin
103. Differential effect of trypsin on infectivity of Chlamydia trachomatis: Loss of infectivity requires cleavage of major outer membrane protein variable domains II and IV
104. Chlamydia trachomatis-induced salpingitis in mice
105. Infertility as a consequence of chlamydial infection of the upper genital tract in female mice
106. IgA-dependent cell-mediated activity against enteropathogenic bacteria: Distribution, specificity, and characterization of the effector cells
107. Antibody-dependent cell-mediated antibacterial activity of intestinal lymphocytes with secretory IgA
108. + lymphocytes armed with IgA antibodies
109. IgA-driven T cell-mediated anti-bacterial immunity in man after live oral Ty 21a vaccine
110. Global data on blindness
111. Viral subversion of the immune system
112. Severity of salpingitis in mice after primary and repeated inoculation with a human strain of Chlamydia trachomatis
113. Salpingitis in mice induced by human strains of Chlamydia trachomatis
114. Cellular interactions involved in Th cell memory
115. Immunotyping of Chlamydia trachomatis with monoclonal antibodies
116. Mechanisms of Chlamydia-induced disease
117. Chlamydia trachomatis antigens on the surface of infected human endometrial epithelial cells
118. DNA vaccination with the major outer membrane protein gene induces acquired immunity to Chlamydia trachomatis (mouse pneumonitis) infection
119. Characterization of immune responses following intramuscular DNA immunization with the MOMP gene of Chlamydia trachomatis mouse pneumonitis strain
120. Protective monoclonal antibodies recognize epitopes located on the major outer membrane protein of Chlamydia trachomatis
121. Protective monoclonal antibodies to Chlamydia trachomatis serovar- and serogroup-specific major outer membrane protein determinants
122. Identification of a chlamydial protease-like activity factor responsible for the degradation of host transcription factors
123. Chlamydia inhibits interferon ginducible major histocompatibility complex II expression by degradation of upstream stimulatory factor 1
124. Degradation of transcription factor RFX5 during the inhibition of both constitutive and interferon-γ-inducible major histocompatibility complex class I expression in chlamydia-infected cells